SIMIELE, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 2.045
EU - Europa 1.569
AS - Asia 920
AF - Africa 73
SA - Sud America 51
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 4
Totale 4.702
Nazione #
US - Stati Uniti d'America 1.976
DE - Germania 570
IT - Italia 418
CN - Cina 364
IN - India 172
GB - Regno Unito 87
FR - Francia 85
JP - Giappone 66
VN - Vietnam 49
NL - Olanda 47
ID - Indonesia 44
RU - Federazione Russa 41
AU - Australia 38
CA - Canada 38
UA - Ucraina 37
CZ - Repubblica Ceca 35
KR - Corea 34
EG - Egitto 30
ES - Italia 30
IR - Iran 30
MX - Messico 28
PL - Polonia 26
AT - Austria 25
TH - Thailandia 24
PK - Pakistan 22
BE - Belgio 20
TR - Turchia 20
HK - Hong Kong 19
BR - Brasile 18
ZA - Sudafrica 18
SE - Svezia 16
HU - Ungheria 15
IE - Irlanda 15
TW - Taiwan 15
RS - Serbia 14
CH - Svizzera 13
RO - Romania 13
CO - Colombia 12
FI - Finlandia 11
SG - Singapore 11
HR - Croazia 9
PH - Filippine 9
MY - Malesia 8
NG - Nigeria 8
CL - Cile 7
DK - Danimarca 7
IL - Israele 7
LT - Lituania 7
SA - Arabia Saudita 7
AR - Argentina 6
GR - Grecia 6
PE - Perù 5
DZ - Algeria 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
EU - Europa 3
KE - Kenya 3
PT - Portogallo 3
SI - Slovenia 3
ZW - Zimbabwe 3
BD - Bangladesh 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
GE - Georgia 2
JO - Giordania 2
KW - Kuwait 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CR - Costa Rica 1
CY - Cipro 1
EE - Estonia 1
GT - Guatemala 1
IQ - Iraq 1
JE - Jersey 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MG - Madagascar 1
MR - Mauritania 1
MT - Malta 1
MU - Mauritius 1
MW - Malawi 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
UG - Uganda 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 4.702
Città #
Fairfield 210
Houston 186
Woodbridge 146
Ashburn 135
Torino 129
Seattle 128
Buffalo 104
Ann Arbor 90
Santa Cruz 90
Cambridge 82
Wilmington 74
Beijing 70
Leawood 55
Nürnberg 48
Chicago 37
San Diego 34
Jinan 33
University Park 30
Dong Ket 26
Nanjing 22
Los Angeles 21
Shanghai 21
Jakarta 20
Wuhan 19
Rome 18
Hangzhou 17
Dallas 16
Guangzhou 16
Hebei 16
Shenyang 16
Hyderabad 15
Amsterdam 14
Changsha 14
Milan 14
Szeged 14
Warsaw 14
Bangkok 13
Las Vegas 13
Mountain View 13
Cairo 12
Gurgaon 12
Ottawa 12
Pisa 12
Tokyo 12
Bengaluru 11
Boardman 11
Chandler 11
Dublin 11
Paris 11
Taipei 11
Central 10
Phoenix 10
Tettnang 10
Cagliari 9
Council Bluffs 9
Haikou 9
Istanbul 9
New Delhi 9
Chengdu 8
Hanoi 8
Herndon 8
Landshut 8
Mumbai 8
Tianjin 8
Turin 8
Bangalore 7
Clearwater 7
Cuneo 7
Helsinki 7
Henderson 7
Lanzhou 7
Madrid 7
Bologna 6
Clifton 6
Düsseldorf 6
Hamburg 6
Ho Chi Minh City 6
Jiaxing 6
Lake Forest 6
London 6
Louvain 6
Lucknow 6
Muizenberg 6
New York 6
Ningbo 6
Osaka 6
Riyadh 6
Seoul 6
Sohag 6
Taiyuan 6
Buenos Aires 5
Ceska 5
Durban 5
Durham 5
Frankfurt am Main 5
Fuzhou 5
Iztacalco 5
Kiel 5
Lima 5
Melbourne 5
Totale 2.497
Nome #
Cannabis FM2: optimization and standardization of galenic preparations., file e27ce42e-b157-2581-e053-d805fe0acbaa 1.009
Ultra Performance Liquid Chromatography PDA Method for Determination of Tigecycline in Human Plasma., file e27ce426-fc6b-2581-e053-d805fe0acbaa 485
HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC)., file e27ce426-eda7-2581-e053-d805fe0acbaa 478
UPLC-MS/MS method for quantification of the azathioprine metabolites 6-mercaptoguanosine and 6-methylmercaptopurine riboside in peripheral blood mononuclear cells., file e27ce427-c7f3-2581-e053-d805fe0acbaa 365
Inosine triphosphatase polymorphisms and ribavirin pharmacokinetics as determinants of ribavirin-associate anemia in patients receiving standard anti-HCV treatment., file e27ce426-edaf-2581-e053-d805fe0acbaa 290
Sviluppo di protocolli operativi standard per l’ottimizzazione di preparazioni galeniche allestite con cannabis “FM2”, file e27ce42e-b155-2581-e053-d805fe0acbaa 290
Intracellular accumulation of ritonavir combined with different protease inhibitors and correlations between concentrations in plasma and peripheral blood mononuclear cells., file e27ce42a-2054-2581-e053-d805fe0acbaa 187
High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysis., file e27ce426-fdb2-2581-e053-d805fe0acbaa 183
Pharmacokinetics of 400 mg of raltegravir once daily in combination with atazanavir/ritonavir plus two nucleoside/nucleotide reverse transcriptase inhibitors., file e27ce42a-3e63-2581-e053-d805fe0acbaa 172
Evaluation of the mean corpuscular volume of peripheral blood mononuclear cells of HIV patients by a coulter counter to determine intracellular drug concentrations., file e27ce426-dd32-2581-e053-d805fe0acbaa 164
Elvitegravir/Cobicistat/Tenofovir/Emtricitabine Penetration in the Cerebrospinal Fluid of Three HIV-Positive Patients, file e27ce429-b6a7-2581-e053-d805fe0acbaa 131
Development of Standard Operating Protocols for the Optimization of Cannabis-Based Formulations for Medical Purposes, file e27ce42e-7b55-2581-e053-d805fe0acbaa 131
Impact of Different Procedures of Galenic Formulations of Cannabis on Cannabinoids Contents, file e27ce42e-813d-2581-e053-d805fe0acbaa 124
Seminal pharmacokinetics and antiviral efficacy of once-daily maraviroc plus lopinavir/ritonavir in HIV-infected patients., file e27ce426-f675-2581-e053-d805fe0acbaa 121
Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients, file e27ce42e-885a-2581-e053-d805fe0acbaa 100
Tenofovir and emtricitabine cerebrospinal fluid-to-plasma ratios correlate to the extent of blood-brainbarrier damage., file e27ce426-d682-2581-e053-d805fe0acbaa 94
Cannabis-Based Oral Formulations for Medical Purposes: Preparation, Quality and Stability, file e27ce431-6848-2581-e053-d805fe0acbaa 94
Raltegravir penetration in seminal plasma of healthy volunteers., file e27ce426-cc1e-2581-e053-d805fe0acbaa 64
Tenofovir clearance is reduced in hiv-positive patients with subclinical tubular impairment, file e27ce429-b2bb-2581-e053-d805fe0acbaa 61
Class-specific relative genetic contribution for key antiretroviral drugs, file e27ce42a-686a-2581-e053-d805fe0acbaa 49
Cerebrospinal Fluid Inhibitory Quotients of Antiretroviral Drugs in HIV-positive Patients are Associated with Compartmental Viral Control., file e27ce42a-5667-2581-e053-d805fe0acbaa 45
Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms., file e27ce42a-40fa-2581-e053-d805fe0acbaa 33
A description of Cannabinoid levels in Cannabis oil by high-performance liquid chromatography-mass spectrometry in a reference laboratory of North-Italy, file e27ce435-5bc4-2581-e053-d805fe0acbaa 33
A UHPLC-MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma, file e27ce433-9ce4-2581-e053-d805fe0acbaa 31
MONITORING OF VIROLOGICAL AND PHARMACOLOGICAL CEREBROSPINAL FLUID PARAMETERS IN HAART-TREATED HIV-POSITIVE PATIENTS IN THE CLINICAL SETTING, file e27ce426-d012-2581-e053-d805fe0acbaa 22
Analytical validation of a novel UHPLC-MS/MS method for 19 antibiotics quantification in plasma: Implementation in a LC-MS/MS Kit, file 759e7a82-b9cd-484a-8443-c3076f5394e4 20
Negative Predictive Value of IL28B, SLC28A2, and CYP27B1 SNPs and Low RBV Plasma Exposure for Therapeutic Response to PEG/IFN-RBV Treatment., file e27ce426-eb1c-2581-e053-d805fe0acbaa 15
Tenofovir clearance is reduced in hiv-positive patients with subclinical tubular impairment, file e27ce429-b616-2581-e053-d805fe0acbaa 9
Cerebrospinal Fluid Inhibitory Quotients of Antiretroviral Drugs in HIV-positive Patients are Associated with Compartmental Viral Control., file e27ce428-c2c0-2581-e053-d805fe0acbaa 6
Plasma and Intracellular Imatinib Concentrations in Patients With Chronic Myeloid Leukemia, file e27ce428-c622-2581-e053-d805fe0acbaa 6
UPLC-MS/MS method for the simultaneous quantification of anti-HBV nucleos(t)ides analogs: Entecavir, lamivudine, telbivudine and tenofovir in plasma of HBV infected patients, file e27ce42c-9b03-2581-e053-d805fe0acbaa 5
UPLC-MS/MS method for quantification of the azathioprine metabolites 6-mercaptoguanosine and 6-methylmercaptopurine riboside in peripheral blood mononuclear cells., file e27ce428-ca8b-2581-e053-d805fe0acbaa 4
UPLC–MS/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasma, file e27ce42b-ee07-2581-e053-d805fe0acbaa 4
A UPLC-MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir., file e27ce432-2134-2581-e053-d805fe0acbaa 4
Stability Study of Fosfomycin in Elastomeric Pumps at 4 °C and 34 °C: Technical Bases for a Continuous Infusion Use for Outpatient Parenteral Antibiotic Therapy, file 91fcba8f-6264-4052-8d06-195798e76738 3
Development and validation of a useful UPLC-MS/MS method for quantification of total and phosphorylated-ribavirin in peripheral blood mononuclear cells of HCV+ patients, file e27ce426-fbb6-2581-e053-d805fe0acbaa 3
Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients, file e27ce426-edae-2581-e053-d805fe0acbaa 2
Clinical pharmacology of tenofovir clearance: a pharmacokinetic/pharmacogenetic study on plasma and urines, file e27ce428-b8e7-2581-e053-d805fe0acbaa 2
Efavirenz pharmacogenetics in a cohort of Italian patients, file e27ce428-bc10-2581-e053-d805fe0acbaa 2
Intracellular antiviral activity of low-dose ritonavir in boosted protease inhibitors regimens., file e27ce428-c7de-2581-e053-d805fe0acbaa 2
QUALITATIVE AND QUANTITATIVE EVALUATION OF DIFFERENT PHARMACEUTICAL PRODUCTS CONTAINING QUETIAPINE: BRAND VERSUS GENERIC, file e27ce42a-ae8b-2581-e053-d805fe0acbaa 2
A UHPLC-MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma, file e27ce42a-c0ee-2581-e053-d805fe0acbaa 2
HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC)., file e27ce42a-ee0b-2581-e053-d805fe0acbaa 2
Cannabinoids concentration variability in cannabis olive oil galenic preparations, file e27ce42c-9627-2581-e053-d805fe0acbaa 2
Atazanavir intracellular concentrations remain stable during pregnancy in HIV-infected patients, file e27ce42c-987e-2581-e053-d805fe0acbaa 2
Negative Predictive Value of IL28B, SLC28A2, and CYP27B1 SNPs and Low RBV Plasma Exposure for Therapeutic Response to PEG/IFN-RBV Treatment., file e27ce432-0d6d-2581-e053-d805fe0acbaa 2
A validated HPLC-MS method for quantification of the CCR5 inhibitor maraviroc in HIV+ human plasma, file e27ce426-fea8-2581-e053-d805fe0acbaa 1
Rilpivirine Pharmacokinetics in 3 HIV-Positive Patients With Liver Cirrhosis Concomitantly Receiving Pantoprazole, file e27ce428-b63c-2581-e053-d805fe0acbaa 1
Development and validation of an ultra performance liquid chromatography tandem mass method for sildenafil and N-desmethyl sildenafil plasma determination and quantification, file e27ce428-b63f-2581-e053-d805fe0acbaa 1
Dried Plasma/Blood Spots for Monitoring Antiretroviral Treatment Efficacy and Pharmacokinetics: a Cross-sectional Study in Rural Burundi., file e27ce428-b6aa-2581-e053-d805fe0acbaa 1
Class-specific relative genetic contribution for key antiretroviral drugs, file e27ce428-baf0-2581-e053-d805fe0acbaa 1
Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms., file e27ce428-c0b7-2581-e053-d805fe0acbaa 1
Development and validation of an UPLC-PDA method to quantify daptomycin in human plasma and in dried plasma spots., file e27ce428-c2dc-2581-e053-d805fe0acbaa 1
High interpatient variability of raltegravir CSF concentrations in HIV-positive patients: a pharmacogenetic analysis., file e27ce428-c358-2581-e053-d805fe0acbaa 1
Elvitegravir/Cobicistat/Tenofovir/Emtricitabine Penetration in the Cerebrospinal Fluid of Three HIV-Positive Patients, file e27ce429-b6a6-2581-e053-d805fe0acbaa 1
Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients, file e27ce42b-f4a4-2581-e053-d805fe0acbaa 1
Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots, file e27ce42b-f4a8-2581-e053-d805fe0acbaa 1
A LC-MS method to quantify tenofovir urinary concentrations in treated patients, file e27ce431-c024-2581-e053-d805fe0acbaa 1
Intrapatient and interpatient pharmacokinetic variability of raltegravir in the clinical setting., file e27ce431-cdd1-2581-e053-d805fe0acbaa 1
Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasma., file e27ce431-e3a9-2581-e053-d805fe0acbaa 1
HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions., file e27ce431-e3ab-2581-e053-d805fe0acbaa 1
An HPLC-PDA Method for the Simultaneous Quantification of the HIV Integrase Inhibitor Raltegravir, the New Nonnucleoside Reverse Transcriptase Inhibitor Etravirine, and 11 Other Antiretroviral Agents in the Plasma of HIV-Infected Patients, file e27ce431-e478-2581-e053-d805fe0acbaa 1
A validated high-performance liquid chromatography-ultraviolet method for quantification of the CCR5 inhibitor maraviroc in plasma of HIV-infected patients., file e27ce431-e479-2581-e053-d805fe0acbaa 1
Influence of CYP2B6 and ABCB1 SNPs on nevirapine plasma concentrations in Burundese HIV-positive patients using dried sample spot devices., file e27ce431-eb75-2581-e053-d805fe0acbaa 1
Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes., file e27ce432-0dc8-2581-e053-d805fe0acbaa 1
Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism., file e27ce432-1daf-2581-e053-d805fe0acbaa 1
Totale 4.875
Categoria #
all - tutte 6.592
article - articoli 0
book - libri 0
conference - conferenze 2.007
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.599


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019264 0 0 0 0 0 0 0 0 0 59 111 94
2019/2020964 61 42 32 109 90 50 79 76 90 211 60 64
2020/2021900 72 65 48 73 67 86 81 79 62 101 88 78
2021/2022915 96 68 65 111 86 34 77 56 54 39 141 88
2022/2023808 65 60 136 93 81 52 53 66 86 63 37 16
2023/2024260 19 27 28 22 21 22 47 47 13 14 0 0
Totale 4.875